Traitement antihypertenseur: Pourquoi et comment?

Translated title of the contribution: Antihypertensive therapy: Why and how?

G. Mancia, G. Grassi

Research output: Contribution to journalArticle

Abstract

Many clinical trials have shown that lowering increased blood pressure by an antihypertensive agent reduces the risk of morbidity and mortality due to hypertension. Despite these beneficial effects, several questions remain largely unanswered, particularly with respect to the degree of cardiovascular protection conferred by the antihypertensive complications. This article addresses some of these questions by reviewing the recommended means of lowering the blood pressure in hypertensive patients. The clinical value of effective blood pressure control throughout the 24 hour period is discussed together with the therapeutic strategies available to obtain this objective.

Original languageFrench
Pages (from-to)41-44
Number of pages4
JournalArchives des Maladies du Coeur et des Vaisseaux
Volume90
Issue numberSPEC. ISS. 5
Publication statusPublished - 1997

Fingerprint

Antihypertensive Agents
Blood Pressure
Therapeutics
Clinical Trials
Hypertension
Morbidity
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Traitement antihypertenseur : Pourquoi et comment? / Mancia, G.; Grassi, G.

In: Archives des Maladies du Coeur et des Vaisseaux, Vol. 90, No. SPEC. ISS. 5, 1997, p. 41-44.

Research output: Contribution to journalArticle

@article{a9451a153ddd4145bebfdef619257280,
title = "Traitement antihypertenseur: Pourquoi et comment?",
abstract = "Many clinical trials have shown that lowering increased blood pressure by an antihypertensive agent reduces the risk of morbidity and mortality due to hypertension. Despite these beneficial effects, several questions remain largely unanswered, particularly with respect to the degree of cardiovascular protection conferred by the antihypertensive complications. This article addresses some of these questions by reviewing the recommended means of lowering the blood pressure in hypertensive patients. The clinical value of effective blood pressure control throughout the 24 hour period is discussed together with the therapeutic strategies available to obtain this objective.",
author = "G. Mancia and G. Grassi",
year = "1997",
language = "Francese",
volume = "90",
pages = "41--44",
journal = "Archives des Maladies du Coeur et des Vaisseaux",
issn = "0003-9683",
publisher = "Editions J B Bailliere",
number = "SPEC. ISS. 5",

}

TY - JOUR

T1 - Traitement antihypertenseur

T2 - Pourquoi et comment?

AU - Mancia, G.

AU - Grassi, G.

PY - 1997

Y1 - 1997

N2 - Many clinical trials have shown that lowering increased blood pressure by an antihypertensive agent reduces the risk of morbidity and mortality due to hypertension. Despite these beneficial effects, several questions remain largely unanswered, particularly with respect to the degree of cardiovascular protection conferred by the antihypertensive complications. This article addresses some of these questions by reviewing the recommended means of lowering the blood pressure in hypertensive patients. The clinical value of effective blood pressure control throughout the 24 hour period is discussed together with the therapeutic strategies available to obtain this objective.

AB - Many clinical trials have shown that lowering increased blood pressure by an antihypertensive agent reduces the risk of morbidity and mortality due to hypertension. Despite these beneficial effects, several questions remain largely unanswered, particularly with respect to the degree of cardiovascular protection conferred by the antihypertensive complications. This article addresses some of these questions by reviewing the recommended means of lowering the blood pressure in hypertensive patients. The clinical value of effective blood pressure control throughout the 24 hour period is discussed together with the therapeutic strategies available to obtain this objective.

UR - http://www.scopus.com/inward/record.url?scp=0030756365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030756365&partnerID=8YFLogxK

M3 - Articolo

C2 - 9436519

AN - SCOPUS:0030756365

VL - 90

SP - 41

EP - 44

JO - Archives des Maladies du Coeur et des Vaisseaux

JF - Archives des Maladies du Coeur et des Vaisseaux

SN - 0003-9683

IS - SPEC. ISS. 5

ER -